← Back to Search

Peer Health Coaching for Women's Health Improvement

N/A

Recruiting

Led By Aisha Lofters, MD, PhD

Research Sponsored by Women's College Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient identifies as a woman;

Patient has an email address;

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 years

Awards & highlights

Study Summary

This trial will test whether adding peer health coaching to a dedicated prevention visit improves health outcomes for women.

Who is the study for?

This trial is for women aged 40-68 in Ontario with an email and health insurance, who have at least one unhealthy behavior or are overdue for cancer screenings. They must be able to consent and communicate in English.Check my eligibility

What is being tested?

The study tests if a prevention visit followed by six months of peer health coaching helps women achieve more health goals compared to just the visit alone. It also examines long-term effects and program implementation.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like coaching, traditional side effects aren't expected. However, participants may experience emotional or psychological impacts from lifestyle changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I identify as a woman.

Select...

I have an email address.

Select...

I am between 40 and 68 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Increased targeted behaviours from baseline

Secondary outcome measures

Alcohol Use Disorder

Alcohol use status

BMI control

+29 more

Other outcome measures

Cardiovascular risk

Duration of intervention effect

Emergency room (ER) visits

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Wait-list ControlExperimental Treatment1 Intervention

Patients will have a prevention visit with a Prevention Practitioner (a healthcare provider who has received additional training) and complete a baseline survey, after which they will receive usual care from their healthcare providers. Patients will be administered another survey at 3 months and a final survey at 6 months. After study completion (about 6-months after the initial prevention visit), patients will be invited to receive ongoing support from a trained, volunteer peer health coach, for up to six months. The coach will support the patient as she works towards achieving personalized health goals to reduce her risk of chronic diseases, including cancer.

Group II: InterventionExperimental Treatment2 Interventions

Patients will have a prevention visit with a Prevention Practitioner (a healthcare provider who has received additional training), complete the baseline survey then be invited to receive ongoing support from a trained, volunteer peer health coach, for up to six months. The coach will support the patient as she works towards achieving personalized health goals to reduce her risk of chronic diseases, including cancer. Patients will be administered additional surveys at 3 and 6 months and a final survey at 12 months.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Women's College HospitalLead Sponsor

100 Previous Clinical Trials

38,395 Total Patients Enrolled

Canadian Cancer Society (CCS)OTHER

78 Previous Clinical Trials

37,337 Total Patients Enrolled

Public Health Agency of Canada (PHAC)OTHER_GOV

45 Previous Clinical Trials

96,725 Total Patients Enrolled

1 Trials studying Chronic Disease

118 Patients Enrolled for Chronic Disease

Media Library

Prevention Visit Clinical Trial Eligibility Overview. Trial Name: NCT04746859 — N/A

Chronic Disease Research Study Groups: Intervention, Wait-list Control

Chronic Disease Clinical Trial 2023: Prevention Visit Highlights & Side Effects. Trial Name: NCT04746859 — N/A

Prevention Visit 2023 Treatment Timeline for Medical Study. Trial Name: NCT04746859 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to become involved in this medical trial?

"This trial seeks 408 female participants aged between 40 and 68 who are living with chronic illness. In addition, they must possess an email address; score less than 9 on the Mediterranean Diet Tool; spend no more than 150 minutes in moderate to vigorous physical activity per week; have smoked a cigarette within the last 30 days; consume at least one alcoholic beverage daily or indulge in binging sessions occasionally; be due for breast, cervical or colorectal cancer screenings and carry a valid number from Ontario Health Insurance Program (OHIP). Furthermore, their medical records must be traceable three years back through their family physician."

Answered by AI

Are participants currently being enrolled in this research trial?

"Affirmative, according to clinicaltrials.gov the trial is currently enrolling patients. It was first posted on June 14th 2021 and amended most recently on July 6th 2022. 408 participants are needed from 3 distinct medical sites for this research project."

Answered by AI

Are there any limitations on the number of participants being admitted to this clinical investigation?

"Indeed, the clinicaltrials.gov website indicates that this trial is still searching for participants. This research was first advertised on June 14th 2021 and has since been updated to July 6th 2022. The study requires 408 volunteers from 3 different medical centres."

Answered by AI